Technical Data
O8065-06A
Osteoprotegerin (OPG, Osteoclastogenesis Inhibitory Factor, OCIF)
Description:
Human OPG (Osteoprotegerin, also know as OCIF
(Osteoclastogenesis inhibitory factor), is a member of the TNF
receptor superfamily. Recombinant human OPG/OCIF specifically acts on bone tissues and increases bone mineral density and bone volume associated with a decrease of active osteoclast number.

Applications:
Suitable for ELISA and Western Blot. Other applications have not been tested.

Recommended Dilutions:
Optimal dilutions to be determined by the researcher.

Storage and Stability:
Lyophilized powder may be stored at -20C. Stable for 12 months at -20C. Reconstitute with sterile ddH2O. Aliquot to avoid repeated freezing and thawing. Store at -20C. Reconstituted product is stable for 12 months at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
TypeIsotypeCloneGrade
MabIgG16D634Affinity Purified
SizeStorageShippingSourceHost
100ug-20CBlue IceHumanMouse
Concentration:
~1mg/ml
Immunogen:
Recombinant human OPG:Fc (osteoprotegerin:Fc).
Purity:
Purified by Protein G affinity chromatography.
Form
Supplied as a lyophilized powder from PBS, pH 7.2. Reconstitute with 100ul sterile ddH2O. Activity is not affected by slight turbidity. Clarify by centrifugation.
Specificity:
Recognizes human OPG.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.